Table 4. Comparison of pain between the mefenamic acid and exercise group in the second cycle.
| Pain | Mefenamic acid | Exercise | p-value |
|---|---|---|---|
| Pain intensity, cm | 33.8±17.7 (29.21–38.29) |
31.6±16.03 (27.46–35.68) |
0.477 |
| Pain duration, days | 1.6±0.7 (1.44 – 1.80) |
1.5±0.7 (1.29–1.69) |
0.378 |
| Pain reduction between the first and the second cycle, mean (SE) | 5.3 (2.24) | 13.9 (2.1) | 0.007 |
| Pain reduction between baseline and the second cycle, mean (SE) | 21.3 (2.91) | 28.7 (2.5) | 0.056 |
| Severity of dysmenorrhea, n (%) | 0.357 | ||
| Mild | 33 (45.8) | 39 (54.2) | |
| Moderate | 28 (56.0) | 22 (44.0) |
Data given as mean ± SD and (95% confidence interval for mean) unless otherwise stated. SE: standard error.